Chinese, Americans Differ on Heparin-Related Deaths
This article is from the archive of The New York Sun before the launch of its new website in 2022. The Sun has neither altered nor updated such articles but will seek to correct any errors, mis-categorizations or other problems introduced during transfer.
America and Chinese officials argued publicly whether a contaminant from China in Baxter International Inc.’s blood-thinner heparin caused allergic reactions and deaths. China determined the contaminant isn’t to blame, and its scientists intend to inspect Baxter’s heparin factory in New Jersey, a Chinese regulator, Jin Shaohong, said at a news conference yesterday in Washington. American regulators concluded the contaminant can trigger the side effects, a Food and Drug Administration official, Janet Woodcock, said in a call with reporters hours later. Eighty-one people given heparin died since January 2007 after suffering allergic reactions according to data released today by the FDA.
